Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5549226 | Neuropharmacology | 2016 | 40 Pages |
Abstract
Here, by combining behavioral, electrophysiological and biochemical techniques, we studied the effects of repeated PPARα stimulation by fenofibrate on mesolimbic dopamine system. We found decreased β2*nAChRs phosphorylation levels and a switch from tonic to phasic activity of dopamine cells in the VTA, and increased phosphorylation of dopamine and cAMP-regulated phosphoprotein Mr 32,000 (DARPP-32) in the NAcS. We then investigated whether long-term fenofibrate administration to stressed rats reinstated the decreased DARPP-32 response to sucrose and whether this effect translated into antidepressant-like properties. Fenofibrate restored dopaminergic responses to appetitive stimuli, reactivity to aversive stimuli and motivation to self-administer sucrose. Overall, this study suggests PPARα as new targets for antidepressant therapies endowed with motivational anti-anhedonic properties, further supporting the role of an unbalanced mesolimbic dopamine system in pathophysiology of depressive disorders.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Simona Scheggi, Miriam Melis, Marta De Felice, Sonia Aroni, Anna Lisa Muntoni, Teresa Pelliccia, Carla Gambarana, Maria Graziella De Montis, Marco Pistis,